KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is making waves in the healthcare sector, particularly within the biotechnology industry. Headquartered in Cambridge, Massachusetts, this biopharmaceutical company is at the forefront of developing..
Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing the attention of investors as a clinical-stage biotechnology firm with a focus on precision medicines targeting fibroblast growth factor receptor (FGFR) biology. With..
Altimmune, Inc. (NASDAQ: ALT) has garnered significant attention from investors, primarily due to its robust potential upside and its strategic focus on high-demand healthcare sectors. With a market capitalization of..
Inventiva S.A. – American Depositary Shares (NASDAQ: IVA) is currently making waves in the biotechnology sector with its intriguing potential for substantial upside. Based in Daix, France, this clinical-stage biopharmaceutical..
Investors are keeping a close watch on Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company operating at the cutting edge of biotechnology. With a focus on developing innovative treatments..
Xencor, Inc. (NASDAQ: XNCR) stands in an intriguing position within the biotechnology sector, offering compelling opportunities for investors who are eyeing the healthcare landscape. With a current market capitalization of..
Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company, has recently captured investor attention given its significant potential upside and unanimous buy ratings from analysts. Headquartered in Needham, Massachusetts, Verastem operates..
Fortrea Holdings Inc. (FTRE), a compelling player in the Biotechnology sector, operates within the Healthcare industry and is headquartered in Durham, North Carolina. Specializing as a contract research organization, Fortrea..
Sana Biotechnology, Inc. (SANA), a pioneering force in the biotechnology sector, has attracted significant investor interest due to its ambitious approach to utilizing engineered cells as medicines. With a focus..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, is making waves in the healthcare sector due to its innovative approach to treating severe autoimmune and inflammatory diseases. With a..
GH Research PLC (NASDAQ: GHRS) is attracting considerable attention in the biotechnology sector, with a striking potential upside of 137.15% according to analysts. This Dublin-based clinical-stage biopharmaceutical company is pioneering..
Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising name in the biotechnology sector, is drawing significant attention from investors with a remarkable potential upside of 211.75%. Specializing in the discovery and..
Vir Biotechnology, Inc. (NASDAQ: VIR) stands out in the biotechnology sector with an impressive potential upside of 254.66%, according to analyst ratings. This San Francisco-based clinical-stage biopharmaceutical company specializes in..
Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, is catching the attention of investors with its substantial potential upside of 13.15%. With a current..
For investors hunting for promising opportunities in the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) presents a compelling case with its significant potential upside. With a market capitalization of $565.18 million,..
Maze Therapeutics, Inc. (NASDAQ: MAZE) is making significant waves in the biotechnology sector, promising investors substantial growth opportunities. With its focus on developing precision medicines, Maze is carving out a..
Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector, specifically within the medical care facilities industry, operates senior housing communities across the United States. With a market..
Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the healthcare sector, specifically within the biotechnology industry. Based in Cambridge, Massachusetts, Relay Therapeutics is a clinical-stage precision medicines company focused..
Claritev Corporation (NASDAQ: CTEV) has emerged as a notable player in the healthcare sector, specializing in health information services. With a market capitalization of $1.17 billion, Claritev operates primarily in..
